Everything looks like it is lining up. FDA granting endpoint approval for Proteinuria, Amicus advising DMX already meets that as confirmed by seeing the interim results thus far, anyone completing the trial is staying on.
Genuinely seeing a run past $1 possibly to $2 by this time next year or sooner....
- Forums
- ASX - By Stock
- DXB Media thread.
DXB
dimerix limited
Add to My Watchlist
1.00%
!
50.5¢

Everything looks like it is lining up. FDA granting endpoint...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
50.5¢ |
Change
0.005(1.00%) |
Mkt cap ! $297.9M |
Open | High | Low | Value | Volume |
51.0¢ | 51.0¢ | 50.0¢ | $587.0K | 1.163M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6888 | 50.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.0¢ | 28145 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 7342 | 0.505 |
5 | 1019297 | 0.500 |
7 | 152748 | 0.495 |
10 | 100933 | 0.490 |
11 | 142762 | 0.485 |
Price($) | Vol. | No. |
---|---|---|
0.510 | 28145 | 7 |
0.515 | 72468 | 4 |
0.520 | 145744 | 4 |
0.525 | 181299 | 3 |
0.535 | 18000 | 1 |
Last trade - 11.44am 19/06/2025 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online